Lamotrigin Orion

Lamotrigine, the active ingredient in Lamotrigin Orion, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed for the treatment of partial seizures in epilepsy and for maintenance therapy in bipolar disorder in adults. It is marketed throughout the European Union and is available by prescription only.

GNH USA supplies Lamotrigin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers.

Lamotrigine is an anticonvulsant that stabilizes neuronal membranes and is used in the following clinical indications:

Partial seizures (epilepsy): Reduces frequency and severity of focal seizures. Bipolar disorder (maintenance therapy): Helps prevent recurrence of mood episodes. Generalized tonic‑clonic seizures: Provides adjunctive seizure control.

Lamotrigine may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Dizziness - Headache - Nausea - Rash - Blurred vision - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., exfoliative dermatitis) - Blood dyscrasias such as agranulocytosis or aplastic anemia

Lamotrigin Orion requires careful consideration of several safety aspects before and during therapy.

Pregnancy: Category D – potential risk to fetus; use only if benefits outweigh risks. Renal or hepatic impairment: Dose may need adjustment; monitor organ function. Concomitant use with valproate: Increased risk of severe skin reactions; avoid if possible. Gradual titration: Initiate at low dose and increase slowly to reduce rash risk. Store at ambient temperature: Keep below 25°C in the original pack, protect from moisture.

Lamotrigin Orion interacts with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Valproic acid: Increases lamotrigine levels, raising toxicity risk. - Carbamazepine, phenytoin, phenobarbital: Decrease lamotrigine concentrations, potentially reducing efficacy. - Oral contraceptives: Lower lamotrigine levels, may necessitate dose adjustment.

Moderate Interactions (Monitor Closely): - Serotonergic agents (SSRIs, SNRIs): May increase risk of serotonin syndrome. - Other antiepileptics (e.g., topiramate): May affect plasma concentrations. - NSAIDs (e.g., ibuprofen): Can slightly raise lamotrigine levels.